Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71205-327

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71205-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This appears to be a medical record with blood pressure readings and medication dosages. There are four medication dosages listed, including Velsartan HCT 320/25 mg, Aan Vasaan 320 mg, Hydrochorothiazide 25 mg, and Placsbo (assumed to be placebo). There is also a graph or chart that appears to plot SBP (systolic blood pressure) readings over time, with a goal of SBP<140 mmHg. However, as the rest of the text is fragmentary and difficult to interpret, the full context and purpose of this record is not available.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This is a tabulated record indicating blood pressure measurements in mmHg taken before and after administration of Valsartan HCT 320/25 mg and Placebo. The medication contains 320 mg of Valsartan and 25 mg of Hydrochlorothiazide. The readings show the baseline DBP was 105 mmHg, and after taking the medication, the DBP was reduced to less than 90 mmHg in some cases.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A description is not available as the text seems to contain medication names and dosages, along with some numerical values indicating blood pressure.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This appears to be a table showing the baseline diastolic blood pressure (DBP) in mmHg for a clinical trial involving the medications Valsartan HCT and Valsartan alone, Hydrochlorothiazide, and a placebo. The baseline DBP values range from 95-105 mmHg.*
FDA Label Image

71205-327-30 (Valsartan Hctz 80 12 5mg 90s Baddi)

71205-327-30 (Valsartan Hctz 80 12 5mg 90s Baddi)
This is a description of a prescription medication called Valsartan HCTZ that comes in 30 tablets per bottle. Each tablet contains 80mg of Valsartan and 12.5mg of Hydrochlorothiazide. The tablets are light orange and oval shaped with "L16" on one side and plain on the other. It is manufactured by Macleods Pharmaceuticals Ltd. in India and packaged by Proficient Rx LP in California. The medication should be stored between 20-25°C and out of reach of children. The provided information includes product ID, lot number, expiration date, and NDC codes.*
FDA Label Image

Valsartan (Valsartan)

FDA Label Image

Hctz-str (Valsartn Hctz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.